The Global Octreotide Market Size is Expected to Grow from USD 3.05 Billion in 2023 to USD 4.11 Billion by 2033, at a CAGR of 3.03% during the forecast period 2023-2033. The octreotide market is the global market that manufactures, distributes, and sells octreotide, a synthetic somatostatin analog medication used for the treatment of diseases like acromegaly, neuroendocrine tumors, and carcinoid syndrome-induced severe diarrhea.